Ike Iheanacho
Ike Iheanacho publishes mostly in Economics and Econometrics, Pulmonary and Respiratory Medicine and Epidemiology, on topics such as Pharmaceutical industry and healthcare, Pharmaceutical Economics and Policy and Health Systems, Economic Evaluations, Quality of Life.
- World rank
- #2,125,295 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #154,613 of 367,258
- Works
- 80
- Citations
- 1.2k
- Citations per work
- 15.1
What does Ike Iheanacho research?
Ike Iheanacho's work is mostly in Medicine (25%), Economics, Econometrics and Finance (12%), Pharmacology, Toxicology and Pharmaceutics (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else4556.4%
- Health Sciences2025.3%
- Medicine2025.3%
- Social Sciences1012.4%
- Life Sciences55.9%
- 1Economics and Econometrics12% of their works
- 2Pulmonary and Respiratory Medicine8% of their works
- 3Epidemiology7% of their works
- 4Pharmacology6% of their works
- 5Hematology5% of their works
- 6Public Health, Environmental and Occupational Health5% of their works
Research topics
- Pharmaceutical industry and healthcare
- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
- Multiple Myeloma Research and Treatments
- Biotechnology and Related Fields
- Botulinum Toxin and Related Neurological Disorders
- Cancer Treatment and Pharmacology
- Chronic Obstructive Pulmonary Disease (COPD) Research
Which keywords describe Ike Iheanacho's research?
The keywords of their largest research topics: Pharmaceutical Industry, Quality of Life, Conflict of Interest, Research Outcome, Drug Development Costs, Generic Drugs, Cost-effectiveness Analysis and Health Utility Measures.
- spirometry
- Neurotoxins
- COPD
- Health Biotechnology
- International Myeloma Working Group
- Health Utility Measures
- Generic Drugs
- Research Outcome
- Quality of Life
- Pharmaceutical Industry
- Conflict of Interest
- Drug Development Costs
- Cost-effectiveness Analysis
- Diagnosis Criteria
- Global Collaboration
- Botulinum Toxin
- Chemotherapy-Induced Peripheral Neuropathy
- Taxanes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Pharmaceutical Industry212 topics
- Quality of Life132 topics
- Conflict of Interest111 topic
- Research Outcome111 topic
- Drug Development Costs101 topic
- Generic Drugs101 topic
- Cost-effectiveness Analysis91 topic
- Health Utility Measures91 topic
- Diagnosis Criteria81 topic
- International Myeloma Working Group81 topic
- Global Collaboration51 topic
- Health Biotechnology51 topic
- Botulinum Toxin41 topic
- COPD41 topic
- Chemotherapy-Induced Peripheral Neuropathy41 topic
- Neurotoxins41 topic
- Taxanes41 topic
- spirometry41 topic
Where does Ike Iheanacho work?
Ike Iheanacho's main affiliation in the publication record is EVRAZ (United Kingdom), United Kingdom.
How many publications and citations does Ike Iheanacho have?
OpenAlex counts 80 works and 1,208 citations for Ike Iheanacho, an h-index of 16, ranking #2,125,295 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ike Iheanacho. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.